Manuel Grossmann
Founding Partner at Amino Collective
Berlin, Berlin
Overview
Work Experience
Founding General Partner and Solo GP
2020 - Current
Amino Collective is an institutional venture capital firm investing at seed stage in health and bio companies. Our mission is to help life-changing ideas come to life. Learn more and see the full portfolio at www.aminocollective.com.
Seed Investor
2024
Seed Investor
2022
Next-generation, bench-top nanopore solutions for comprehensive, full–length, single-molecule protein characterisation.
Seed Investor
2022
Seed Investor
2021
Lindus Health is a next-gen CRO running clinical trials for the health and biotech sectors.
Raised $24,545,079.00 from Seedcamp, Peter Thiel, Page One Ventures, Salica, Calm/Storm Ventures, Amino Collective, Firstminute Capital and Creandum.
Seed Investor
2021
Seed Investor
2021
Seed Investor
2021
The next generation care enablement platform
Raised $14,625,000.00 from Hummingbird Ventures, Amino Collective, Sidar Sahin, Y Combinator and Molten Ventures.
Seed Investor
2020 - 2021
Acquired by Exscientia which went public at NASDAQ and then merged with Recursion.
Director Business Development
2018 - 2020
KRY is Europe's leading digital-first healthcare provider with a mission to provide better access and efficient care for everyone. Backed by Index Ventures, Accel, Creandum, OTPP and Project A, among others.